DIN |
Brand Name |
Chemical Name |
ATC |
Dosage |
Comments |
Status |
01947664 |
ACCUPRIL - 5 MG/TABLET |
quinapril hydrochloride |
C09AA |
Oral Solid - Tablet |
blank |
Within Guidelines |
01947672 |
ACCUPRIL - 10 MG/TABLET |
quinapril hydrochloride |
C09AA |
Oral Solid - Tablet |
blank |
Within Guidelines |
01947680 |
ACCUPRIL - 20 MG/TABLET |
quinapril hydrochloride |
C09AA |
Oral Solid - Tablet |
blank |
Within Guidelines |
01947699 |
ACCUPRIL - 40 MG/TABLET |
quinapril hydrochloride |
C09AA |
Oral Solid - Tablet |
blank |
Within Guidelines |
02237367 |
ACCURETIC 10/12.5 |
quinapril hydrochloride/ hydrochlorothiazide |
C09BA |
Oral Solid - Tablet |
blank |
Within Guidelines |
02237368 |
ACCURETIC 20/12.5 |
quinapril hydrochloride/ hydrochlorothiazide |
C09BA |
Oral Solid - Tablet |
blank |
Within Guidelines |
02237369 |
ACCURETIC 20/25 |
quinapril hydrochloride/ hydrochlorothiazide |
C09BA |
Oral Solid - Tablet |
blank |
Within Guidelines |
02232043 |
ARICEPT - 5 MG/TABLET |
donepezil hydrochloride |
N06DA |
Oral Solid - Tablet |
blank |
Within Guidelines |
02232044 |
ARICEPT - 10 MG/TABLET |
donepezil hydrochloride |
N06DA |
Oral Solid - Tablet |
blank |
Within Guidelines |
02269457 |
ARICEPT RDT - 5 MG/TABLET |
donepezil hydrochloride |
N06DA |
Oral Solid - Tablet |
blank |
Does Not Trigger |
02269465 |
ARICEPT RDT - 10 MG/TABLET |
donepezil hydrochloride |
N06DA |
Oral Solid - Tablet |
blank |
Within Guidelines |
02242705 |
AROMASIN - 25 MG/TABLET |
exemestane |
L02BG |
Oral Solid - Tablet |
blank |
Within Guidelines |
02293773 |
BENEFIX - 500 UNIT/VIAL |
coagulation factor ix (recombinant) |
B02BD |
Parenteral - Powder for solution |
blank |
Within Guidelines |
02293781 |
BENEFIX - 1000 UNIT/VIAL |
coagulation factor ix (recombinant) |
B02BD |
Parenteral - Powder for solution |
blank |
Within Guidelines |
02293803 |
BENEFIX - 2000 UNIT/VIAL |
coagulation factor ix (recombinant) |
B02BD |
Parenteral - Powder for solution |
blank |
Within Guidelines |
02392984 |
BENEFIX - 3000 UNIT/VIAL |
coagulation factor ix (recombinant) |
B02BD |
Parenteral - Powder for solution |
blank |
Does Not Trigger |
02419149 |
BOSULIF - 100 MG/TABLET |
bosutinib |
L01XE |
Oral Solid - Tablet |
Introduced |
Within Guidelines |
02419157 |
BOSULIF - 500 MG/TABLET |
bosutinib |
L01XE |
Oral Solid - Tablet |
Introduced |
Within Guidelines |
02273233 |
CADUET 5/10 |
amlodipine besylate/atorvastatin calcium |
C10BX |
Oral Solid - Tablet |
blank |
Within Guidelines |
02273241 |
CADUET 5/20 |
amlodipine besylate/atorvastatin calcium |
C10BX |
Oral Solid - Tablet |
blank |
Within Guidelines |
02273268 |
CADUET 5/40 |
amlodipine besylate/atorvastatin calcium |
C10BX |
Oral Solid - Tablet |
blank |
Within Guidelines |
02273276 |
CADUET 5/80 |
amlodipine besylate/atorvastatin calcium |
C10BX |
Oral Solid - Tablet |
blank |
Within Guidelines |
02273284 |
CADUET 10/10 |
amlodipine besylate/atorvastatin calcium |
C10BX |
Oral Solid - Tablet |
blank |
Within Guidelines |
02273292 |
CADUET 10/20 |
amlodipine besylate/atorvastatin calcium |
C10BX |
Oral Solid - Tablet |
blank |
Within Guidelines |
02273306 |
CADUET 10/40 |
amlodipine besylate/atorvastatin calcium |
C10BX |
Oral Solid - Tablet |
blank |
Within Guidelines |
02273314 |
CADUET 10/80 |
amlodipine besylate/atorvastatin calcium |
C10BX |
Oral Solid - Tablet |
blank |
Within Guidelines |
02231622 |
CAMPTOSAR - 20 MG/MILLILITRE |
irinotecan hydrochloride |
L01XX |
Parenteral - Solution |
blank |
Within Guidelines |
02239941 |
CELEBREX - 100 MG/CAPSULE |
celecoxib |
M01AH |
Oral Solid - Capsule |
blank |
Subj. Investigation |
02239942 |
CELEBREX - 200 MG/CAPSULE |
celecoxib |
M01AH |
Oral Solid - Capsule |
blank |
Subj. Investigation |
02291177 |
CHAMPIX - 0.5 MG/TABLET |
varenicline tartrate |
N07BA |
Oral Solid - Tablet |
blank |
Within Guidelines |
02291185 |
CHAMPIX - 1 MG/TABLET |
varenicline tartrate |
N07BA |
Oral Solid - Tablet |
blank |
Within Guidelines |
02298309 |
CHAMPIX |
varenicline tartrate |
N07BA |
Oral Solid - Tablet |
blank |
Within Guidelines |
02132680 |
COLESTID - 1000 MG/TABLET |
colestipol hydrochloride |
C10AC |
Oral Solid - Tablet |
blank |
Within Guidelines |
02132699 |
COLESTID ORANGE - 7500 MG/DOSE |
colestipol hydrochloride |
C10AC |
Oral Solid - Effervescent granules |
blank |
Within Guidelines |
02406764 |
CYTARABINE - 20 MG/MILLILITRE |
cytarabine |
L01BC |
Parenteral - Solution |
Introduced |
Within Guidelines |
02406772 |
CYTARABINE - 100 MG/MILLILITRE |
cytarabine |
L01BC |
Parenteral - Solution |
Introduced |
Within Guidelines |
00386715 |
CYTOSAR - 20 MG/MILLILITRE |
cytarabine |
L01BC |
Parenteral - Solution |
blank |
Under Review - FTR |
00646296 |
CYTOSAR - 100 MILLILITRE |
cytarabine |
L01BC |
Parenteral - Solution |
blank |
Under Review - FTR |
00646318 |
CYTOSAR - 100 MILLILITRE |
cytarabine |
L01BC |
Parenteral - Powder for solution |
blank |
Under Review - FTR |
02239064 |
DETROL - 1 MG/TABLET |
tolterodine tartrate |
G04BD |
Oral Solid - Tablet |
blank |
Within Guidelines |
02239065 |
DETROL - 2 MG/TABLET |
tolterodine tartrate |
G04BD |
Oral Solid - Tablet |
blank |
Within Guidelines |
02244612 |
DETROL LA - 2 MG/CAPSULE |
tolterodine tartrate |
G04BD |
Oral Solid - Modified release capsules |
blank |
Within Guidelines |
02244613 |
DETROL LA - 4 MG/CAPSULE |
tolterodine tartrate |
G04BD |
Oral Solid - Modified release capsules |
blank |
Within Guidelines |
00891835 |
DIFLUCAN - 2 MG/MILLILITRE |
fluconazole |
J02AC |
Parenteral - Solution |
blank |
Subj. Investigation |
02237279 |
EFFEXOR XR - 37.5 MG/CAPSULE |
venlafaxine hydrochloride |
N06AA |
Oral Solid - Modified release capsules |
blank |
Does Not Trigger |
02237280 |
EFFEXOR XR - 75 MG/CAPSULE |
venlafaxine hydrochloride |
N06AA |
Oral Solid - Modified release capsules |
blank |
Within Guidelines |
02237282 |
EFFEXOR XR - 150 MG/CAPSULE |
venlafaxine hydrochloride |
N06AA |
Oral Solid - Modified release capsules |
blank |
Within Guidelines |
02425637 |
ELELYSO - 200 UNIT/VIAL |
taliglucerace alpha |
blank |
Parenteral - Solution |
Introduced |
Within Guidelines |
02330695 |
ERAXIS (WITHOUT SOLVENT) - 100 MG/VIAL |
anidulafungin |
J02AX |
Parenteral - Powder for solution |
blank |
Subj. Investigation |
02401762 |
GENOTROPIN - 0.6 MG/SYRINGE |
somatropin |
H01AC |
Parenteral - Powder for solution |
blank |
Within Guidelines |
02401770 |
GENOTROPIN - 0.8 MG/SYRINGE |
somatropin |
H01AC |
Parenteral - Powder for solution |
blank |
Within Guidelines |
02401789 |
GENOTROPIN - 1 MG/SYRINGE |
somatropin |
H01AC |
Parenteral - Powder for solution |
blank |
Within Guidelines |
02401797 |
GENOTROPIN - 1.2 MG/SYRINGE |
somatropin |
H01AC |
Parenteral - Powder for solution |
blank |
Within Guidelines |
02401800 |
GENOTROPIN - 1.4 MG/SYRINGE |
somatropin |
H01AC |
Parenteral - Powder for solution |
blank |
Within Guidelines |
02401819 |
GENOTROPIN - 1.6 MG/SYRINGE |
somatropin |
H01AC |
Parenteral - Powder for solution |
blank |
Within Guidelines |
02401827 |
GENOTROPIN - 1.8 MG/SYRINGE |
somatropin |
H01AC |
Parenteral - Powder for solution |
blank |
Within Guidelines |
02401835 |
GENOTROPIN - 2 MG/SYRINGE |
somatropin |
H01AC |
Parenteral - Powder for solution |
blank |
Within Guidelines |
02401703 |
GENOTROPIN - 5.3 MG/PEN |
somatropin |
H01AC |
Parenteral - Powder for solution |
blank |
Within Guidelines |
02401711 |
GENOTROPIN - 12 MG/PEN |
somatropin |
H01AC |
Parenteral - Powder for solution |
blank |
Within Guidelines |
02389630 |
INLYTA - 1 MG/TABLET |
axitinib |
L01XE |
Oral Solid - Tablet |
blank |
Within Guidelines |
02389649 |
INLYTA - 5 MG/TABLET |
axitinib |
L01XE |
Oral Solid - Tablet |
blank |
Within Guidelines |
02410419 |
IRINOTECAN - 20 MG/MILLILITRE |
irinotecan hydrochloride trihydrate |
L01XX |
Parenteral - Solution |
Introduced |
Subj. Investigation |
02230711 |
LIPITOR - 10 MG/TABLET |
atorvastatin calcium |
C10AA |
Oral Solid - Tablet |
blank |
Does Not Trigger |
02230713 |
LIPITOR - 20 MG/TABLET |
atorvastatin calcium |
C10AA |
Oral Solid - Tablet |
blank |
Does Not Trigger |
02230714 |
LIPITOR - 40 MG/TABLET |
atorvastatin calcium |
C10AA |
Oral Solid - Tablet |
blank |
Does Not Trigger |
02243097 |
LIPITOR - 80 MG/TABLET |
atorvastatin calcium |
C10AA |
Oral Solid - Tablet |
blank |
Does Not Trigger |
02268418 |
LYRICA - 25 MG/CAPSULE |
pregabalin |
N03AX |
Oral Solid - Capsule |
blank |
Within Guidelines |
02268426 |
LYRICA - 50 MG/CAPSULE |
pregabalin |
N03AX |
Oral Solid - Capsule |
blank |
Within Guidelines |
02268434 |
LYRICA - 75 MG/CAPSULE |
pregabalin |
N03AX |
Oral Solid - Capsule |
blank |
Within Guidelines |
02268450 |
LYRICA - 150 MG/CAPSULE |
pregabalin |
N03AX |
Oral Solid - Capsule |
blank |
Within Guidelines |
02268477 |
LYRICA - 225 MG/CAPSULE |
pregabalin |
N03AX |
Oral Solid - Capsule |
blank |
Within Guidelines |
02268485 |
LYRICA - 300 MG/CAPSULE |
pregabalin |
N03AX |
Oral Solid - Capsule |
blank |
Within Guidelines |
02084260 |
NEURONTIN - 100 MG/CAPSULE |
gabapentin |
N03AX |
Oral Solid - Capsule |
blank |
Within Guidelines |
02084279 |
NEURONTIN - 300 MG/CAPSULE |
gabapentin |
N03AX |
Oral Solid - Capsule |
blank |
Does Not Trigger |
02084287 |
NEURONTIN - 400 MG/CAPSULE |
gabapentin |
N03AX |
Oral Solid - Capsule |
blank |
Does Not Trigger |
02239717 |
NEURONTIN - 600 MG/TABLET |
gabapentin |
N03AX |
Oral Solid - Tablet |
blank |
Within Guidelines |
02239718 |
NEURONTIN - 800 MG/TABLET |
gabapentin |
N03AX |
Oral Solid - Tablet |
blank |
Within Guidelines |
00878928 |
NORVASC - 5 MG/TABLET |
amlodipine besylate |
C08CA |
Oral Solid - Tablet |
blank |
Within Guidelines |
00878936 |
NORVASC - 10 MG/TABLET |
amlodipine besylate |
C08CA |
Oral Solid - Tablet |
blank |
Subj. Investigation |
02335204 |
PREVNAR 13 |
pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) |
J07AL |
Parenteral - Suspensions or Emulsions |
blank |
Within Guidelines |
02321092 |
PRISTIQ - 50 MG/TABLET |
desvenlafaxine succinate |
N06AX |
Oral Solid - Modified release tablets |
blank |
Subj. Investigation |
02321106 |
PRISTIQ - 100 MG/TABLET |
desvenlafaxine succinate |
N06AX |
Oral Solid - Modified release tablets |
blank |
Subj. Investigation |
02243237 |
RAPAMUNE - 1 MG/MILLILITRE |
sirolimus |
L04AA |
Oral Liquid - Solution |
blank |
Within Guidelines |
02247111 |
RAPAMUNE - 1 MG/TABLET |
sirolimus |
L04AA |
Oral Solid - Tablet |
blank |
Within Guidelines |
02256290 |
RELPAX - 20 MG/TABLET |
eletriptan hydrobromide |
N02CC |
Oral Solid - Tablet |
blank |
Within Guidelines |
02256304 |
RELPAX - 40 MG/TABLET |
eletriptan hydrobromide |
N02CC |
Oral Solid - Tablet |
blank |
Within Guidelines |
02279401 |
REVATIO - 20 MG/TABLET |
sildenafil citrate |
G04BE |
Oral Solid - Tablet |
blank |
Within Guidelines |
02341611 |
REVATIO IV - 0.8 MG/MILLILITRE |
sildenafil citrate |
G04BE |
Parenteral - Solution |
blank |
Within Guidelines |
02272199 |
SOMAVERT - 10 MG/VIAL |
pegvisomant |
H01AX |
Parenteral - Powder for solution |
blank |
Within Guidelines |
02272202 |
SOMAVERT - 15 MG/VIAL |
pegvisomant |
H01AX |
Parenteral - Powder for solution |
blank |
Within Guidelines |
02272210 |
SOMAVERT - 20 MG/VIAL |
pegvisomant |
H01AX |
Parenteral - Powder for solution |
blank |
Within Guidelines |
02280795 |
SUTENT - 12.5 MG/CAPSULE |
sunitinib malate |
L01XE |
Oral Solid - Capsule |
blank |
Within Guidelines |
02280809 |
SUTENT - 25 MG/CAPSULE |
sunitinib malate |
L01XE |
Oral Solid - Capsule |
blank |
Within Guidelines |
02280817 |
SUTENT - 50 MG/CAPSULE |
sunitinib malate |
L01XE |
Oral Solid - Capsule |
blank |
Within Guidelines |
02170817 |
TAZOCIN 2000/250 |
piperacillin sodium/tazobactam sodium |
J01CR |
Parenteral - Powder for solution |
blank |
Does Not Trigger |
02170795 |
TAZOCIN 3000/375 |
piperacillin sodium/tazobactam sodium |
J01CR |
Parenteral - Powder for solution |
blank |
Does Not Trigger |
02170809 |
TAZOCIN 4000/500 |
piperacillin sodium/tazobactam sodium |
J01CR |
Parenteral - Powder for solution |
blank |
Does Not Trigger |
02304104 |
TORISEL - 25 MG/VIAL |
temsirolimus |
L01XE |
Parenteral - Solution |
blank |
Within Guidelines |
02380021 |
TOVIAZ - 4 MG/TABLET |
fesoterodine fumarate |
G04BD |
Oral Solid - Modified release tablets |
blank |
Within Guidelines |
02380048 |
TOVIAZ - 8 MG/TABLET |
fesoterodine fumarate |
G04BD |
Oral Solid - Modified release tablets |
blank |
Within Guidelines |
02285401 |
TYGACIL - 50 MG/VIAL |
tigecycline |
J01AA |
Parenteral - Powder for solution |
blank |
Within Guidelines |
02279991 |
VFEND - 40 MG/MILLILITRE |
voriconazole |
J02AC |
Oral Liquid - Powder for suspension |
blank |
Within Guidelines |
02256460 |
VFEND - 50 MG/TABLET |
voriconazole |
J02AC |
Oral Solid - Tablet |
blank |
Within Guidelines |
02256479 |
VFEND - 200 MG/TABLET |
voriconazole |
J02AC |
Oral Solid - Tablet |
blank |
Within Guidelines |
02256487 |
VFEND - 200 MG/VIAL |
voriconazole |
J02AC |
Parenteral - Powder for solution |
blank |
Within Guidelines |
02239766 |
VIAGRA - 25 MG/TABLET |
sildenafil citrate |
G04BE |
Oral Solid - Tablet |
blank |
Within Guidelines |
02239767 |
VIAGRA - 50 MG/TABLET |
sildenafil citrate |
G04BE |
Oral Solid - Tablet |
blank |
Within Guidelines |
02239768 |
VIAGRA - 100 MG/TABLET |
sildenafil citrate |
G04BE |
Oral Solid - Tablet |
blank |
Within Guidelines |
02246619 |
XALACOM 0.05/5 |
latanoprost/timolol maleate |
S01ED |
Ophthalmic - Drops |
blank |
Within Guidelines |
02231493 |
XALATAN - 0.05 MG/MILLILITRE |
latanoprost |
S01EE |
Ophthalmic - Liquid |
blank |
Within Guidelines |
02384256 |
XALKORI - 200 MG/CAPSULE |
crizotinib |
L01XE |
Oral Solid - Capsule |
blank |
Subj. Investigation |
02384264 |
XALKORI - 250 MG/CAPSULE |
crizotinib |
L01XE |
Oral Solid - Capsule |
blank |
Subj. Investigation |
02423898 |
XELJANZ - 5 MG/TABLET |
tofacitinib |
L04AA |
Oral Solid - Tablet |
Introduced |
Under Review |
02309483 |
XYNTHA - 250 UNIT/VIAL |
moroctocog alpha |
B02BD |
Parenteral - Powder for solution |
blank |
Within Guidelines |
02309491 |
XYNTHA - 500 UNIT/VIAL |
moroctocog alpha |
B02BD |
Parenteral - Powder for solution |
blank |
Within Guidelines |
02374072 |
XYNTHA SOLOFUSE - 1000 UNIT/SYRINGE |
moroctocog alpha |
B02BD |
Parenteral - Powder for solution |
blank |
Within Guidelines |
02374080 |
XYNTHA SOLOFUSE - 2000 UNIT/SYRINGE |
moroctocog alpha |
B02BD |
Parenteral - Powder for solution |
blank |
Does Not Trigger |
02374099 |
XYNTHA SOLOFUSE - 3000 UNIT/SYRINGE |
moroctocog alpha |
B02BD |
Parenteral - Powder for solution |
blank |
Does Not Trigger |
02298597 |
ZELDOX - 20 MG/CAPSULE |
ziprasidone hydrochloride |
N05AE |
Oral Solid - Capsule |
blank |
Does Not Trigger |
02298600 |
ZELDOX - 40 MG/CAPSULE |
ziprasidone hydrochloride |
N05AE |
Oral Solid - Capsule |
blank |
Does Not Trigger |
02298619 |
ZELDOX - 60 MG/CAPSULE |
ziprasidone hydrochloride |
N05AE |
Oral Solid - Capsule |
blank |
Does Not Trigger |
02298627 |
ZELDOX - 80 MG/CAPSULE |
ziprasidone hydrochloride |
N05AE |
Oral Solid - Capsule |
blank |
Does Not Trigger |
02223716 |
ZITHROMAX - 20 MG/MILLILITRE |
azithromycin |
J01FA |
Oral Liquid - Powder for suspension |
blank |
Within Guidelines |
02223724 |
ZITHROMAX - 40 MG/MILLILITRE |
azithromycin |
J01FA |
Oral Liquid - Powder for suspension |
blank |
Within Guidelines |
02212021 |
ZITHROMAX - 250 MG/TABLET |
azithromycin |
J01FA |
Oral Solid - Tablet |
blank |
Within Guidelines |
02239952 |
ZITHROMAX - 500 MG/VIAL |
azithromycin |
J01FA |
Parenteral - Powder for solution |
blank |
Within Guidelines |
02354802 |
ZMAX SR - 2 G/BOTTLE |
azithromycin |
J01FA |
Oral Liquid - Powder for suspension |
blank |
Does Not Trigger |
02132702 |
ZOLOFT - 25 MG/CAPSULE |
sertraline hydrochloride |
N06AB |
Oral Solid - Capsule |
blank |
Within Guidelines |
01962817 |
ZOLOFT - 50 MG/CAPSULE |
sertraline hydrochloride |
N06AB |
Oral Solid - Capsule |
blank |
Within Guidelines |
01962779 |
ZOLOFT - 100 MG/CAPSULE |
sertraline hydrochloride |
N06AB |
Oral Solid - Capsule |
blank |
Within Guidelines |
02243686 |
ZYVOXAM - 20 MG/MILLILITRE |
linezolid |
J01XX |
Oral Liquid - Powder for suspension |
blank |
Does Not Trigger |
02243684 |
ZYVOXAM - 600 MG/TABLET |
linezolid |
J01XX |
Oral Solid - Tablet |
Expired |
Within Guidelines |
02243685 |
ZYVOXAM - 2 MG/MILLILITRE |
linezolid |
J01XX |
Parenteral - Solution |
Expired |
Within Guidelines |